Themis Medicare Board Approves FY26 Results and Recommends 50% Dividend
Themis Medicare Limited approved audited standalone and consolidated financial results for FY26. Recommended a final dividend of Re. 0.50 per equity share. Appointed M/s. R. Nanabhoy & Co. as Cost Auditor for FY27.
The approval of financial results and dividend recommendation are material information for investors. The net loss for the year may impact investor sentiment, while the dividend is a positive factor.
The company reported a net loss for the full financial year on a standalone basis, which is a negative indicator. However, the recommendation of a dividend and the approval of financial results are neutral to positive developments.
Themis Medicare Limited announced the outcome of its Board Meeting held on May 28, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported a net profit of ₹196.56 lakhs for the quarter ended March 31, 2026, and a net loss of ₹1,418.55 lakhs for the full financial year ended March 31, 2026. For the consolidated results, the company reported a profit of ₹888.54 lakhs for the quarter and a profit of ₹905.56 lakhs for the year ended March 31, 2026.
The Board recommended a final dividend of Re. 0.50 per equity share (50% dividend) for the Financial Year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting. Additionally, M/s. R. Nanabhoy & Co. has been appointed as the Cost Auditor for the Financial Year 2026-27.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.